Edgar Tracker

TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD

NYSE · CIK 818686 · Pharmaceutical Preparations

SEC company page

Public articles

No public articles yet. Follow TEVA to track filings and write notes.

Recent filings

–

Form Filed Title Accession
32026-10-0830001193125-26-417902
8-K2026-09-161.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and Exhibits0001193125-26-393116
8-K2026-09-148.01 Other Events0001193125-26-390562
8-A12B/A2026-09-148-A12B/A0001193125-26-390559
25-NSE2026-09-14—0000876661-26-000744
424B52026-09-11424B50001193125-26-389382
8-K2026-09-117.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-389264
FWP2026-09-10FWP0001193125-26-387112
FWP2026-09-10FWP0001193125-26-387100
424B52026-09-08424B50001193125-26-384343
8-K2026-09-038.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-381899
8-K2026-09-033.03 Material Modification to Rights of Security Holders · 9.01 Financial Statements and Exhibits0001193125-26-381879
F-6 POS2026-07-29—0001193805-26-001006
10-Q2026-07-2910-Q0001193125-26-323619
8-K2026-07-292.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001171843-26-004974
8-K2026-05-285.07 Submission of Matters to a Vote of Security Holders0001193125-26-245203
10-Q2026-04-2910-Q0001193125-26-191513
8-K2026-04-292.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001171843-26-002796
DEFA14A2026-03-31DEFA14A0001193125-26-134787
ARS2026-03-31ARS0001193125-26-134777